ArticleMolecular oncology2021

Androgen receptor signalling confers clonogenic and migratory advantages in urothelial cell carcinoma of the bladder.

Maria V Luna-Velez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.